1. Home
  2. NTNX vs TECH Comparison

NTNX vs TECH Comparison

Compare NTNX & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutanix Inc.

NTNX

Nutanix Inc.

HOLD

Current Price

$42.01

Market Cap

9.1B

Sector

Technology

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$51.96

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTNX
TECH
Founded
2009
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
8.6B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
NTNX
TECH
Price
$42.01
$51.96
Analyst Decision
Buy
Strong Buy
Analyst Count
19
11
Target Price
$62.29
$71.82
AVG Volume (30 Days)
3.1M
1.9M
Earning Date
05-27-2026
05-06-2026
Dividend Yield
N/A
0.60%
EPS Growth
227.45
N/A
EPS
0.57
0.49
Revenue
$2,537,927,000.00
$1,219,635,000.00
Revenue This Year
$13.44
$2.49
Revenue Next Year
$13.03
$6.40
P/E Ratio
$72.55
$109.34
Revenue Growth
18.11
5.23
52 Week Low
$34.01
$46.05
52 Week High
$83.36
$72.16

Technical Indicators

Market Signals
Indicator
NTNX
TECH
Relative Strength Index (RSI) 58.48 40.58
Support Level $35.23 $49.55
Resistance Level $42.19 $57.37
Average True Range (ATR) 1.59 2.52
MACD 0.38 -0.55
Stochastic Oscillator 95.24 8.13

Price Performance

Historical Comparison
NTNX
TECH

About NTNX Nutanix Inc.

Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company operates a single operating and reportable segment based on a subscription business model. It conducts business in the United States, Europe, the Middle East and Africa, Asia Pacific, and other Americas, with key revenue generated from the United States.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: